Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novogen Ltd (NASDAQ:NVGN)

3.45
Delayed Data
As of Jul 27
 +0.2901 / +9.18%
Today’s Change
2.61
Today|||52-Week Range
9.76
-41.12%
Year-to-Date
No recent news for Novogen Ltd.

Today’s Trading

Previous close3.16
Today’s open3.20
Day’s range3.20 - 3.82
Volume55,373
Average volume (3 months)11,098
Market cap$15.3M
Dividend yield--
Data as of 3:55pm ET, 07/27/2017

Growth & Valuation

Earnings growth (last year)+17.60%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
EYEGEyeGate Pharmaceutic...-0.02-1.43%
ANTHAnthera Pharmaceutic...-0.04-3.02%
SBOTStellar Biotechnolog...-0.03-2.08%
APRIApricus Biosciences ...-0.09-7.14%
Data as of 4:00pm ET, 07/27/2017

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
James Garner
Chief Business Officer
Peng Leong
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts